
Upstream Bio, Inc.
UPBHealthcare|Biotechnology|US
$3.23
+0.02 (+0.62%)
Tangible Book / Share
$4.97
Cash / Share
$4.79
Ownership Breakdown
36.9%
Float
54.8M
Shares Outstanding
20.2M
Float Shares
Major Holders (11)
Combined: 57.2%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Norges Bank | FI, OO | 7.73% | 4,206,586 | Aug 12, 2026 | 13D/G |
| FMR LLC | Holding company | 6.90% | 3,793,955 | Nov 6, 2026 | 13D/G |
| Abigail P. Johnson | Individual | 6.90% | 3,793,955 | Nov 6, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 5.20% | 2,814,714 | Jul 30, 2026 | 13D/G |
| Decheng Capital Global Life Sciences Fund IV, L.P. | Partnership | 4.90% | 2,724,868 | Oct 29, 2026 | 13D/G |
| Decheng Capital Management IV (Cayman), LLC | Other | 4.90% | 2,724,868 | Oct 29, 2026 | 13D/G |
| Xiangmin Cui | Individual | 4.90% | 2,724,868 | Oct 29, 2026 | 13D/G |
| HBM Healthcare Investments (Cayman) Ltd. | Corporation | 4.10% | 2,195,111 | Nov 14, 2025 | 13D/G |
| Chen Yu | Individual | 3.90% | 2,117,103 | Nov 14, 2025 | 13D/G |
| TCG Crossover GP I, LLC | Other | 3.90% | 2,117,103 | Nov 14, 2025 | 13D/G |
| TCG Crossover Fund I, L.P. | Partnership | 3.90% | 2,117,103 | Nov 14, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 923,152 acquired · 15,061 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| GRAY MICHAEL | CFO and COO | Sep 16, 2026 | SELL | 853 | $5.49 | $4.7K | Form 4 |
| Ambrose Allison | General Counsel | Sep 16, 2026 | SELL | 485 | $5.49 | $2.7K | Form 4 |
| Deykin Aaron | Chief Medical Officer | Sep 16, 2026 | SELL | 895 | $5.49 | $4.9K | Form 4 |
| Sutherland Everett Rand | director, officer: Chief Executive Officer | Sep 16, 2026 | SELL | 2,095 | $5.49 | $11.5K | Form 4 |
| Houghton Adam | Chief Business Officer | Sep 16, 2026 | SELL | 700 | $5.49 | $3.8K | Form 4 |
| GRAY MICHAEL | CFO and COO | Jun 16, 2026 | SELL | 853 | $6.10 | $5.2K | Form 4 |
| Sutherland Everett Rand | director, officer: Chief Executive Officer | Jun 16, 2026 | SELL | 2,095 | $6.10 | $12.8K | Form 4 |
| Houghton Adam | Chief Business Officer | Jun 16, 2026 | SELL | 700 | $6.10 | $4.3K | Form 4 |
| Deykin Aaron | Chief Medical Officer | Jun 16, 2026 | SELL | 895 | $6.10 | $5.5K | Form 4 |
| Ambrose Allison | General Counsel | Jun 16, 2026 | SELL | 477 | $6.10 | $2.9K | Form 4 |
| Ruddy Marcella K. | director | Jun 9, 2026 | AWARD | 17,096 | $6.69 | $114.4K | Form 4 |
| Renaud Ronald C JR | director | Jun 9, 2026 | AWARD | 17,096 | $6.69 | $114.4K | Form 4 |
| Fleming Harold Edward | director | Jun 9, 2026 | AWARD | 17,096 | $6.69 | $114.4K | Form 4 |
| Beckman Daniella | director | Jun 9, 2026 | AWARD | 17,096 | $6.69 | $114.4K | Form 4 |
| Ratcliffe Liam | director | Jun 9, 2026 | AWARD | 17,096 | $6.69 | $114.4K | Form 4 |
| Chimovits Erez | director | Jun 9, 2026 | AWARD | 17,096 | $6.69 | $114.4K | Form 4 |
| GRAY MICHAEL | CFO and COO | Mar 16, 2026 | SELL | 852 | $9.29 | $7.9K | Form 4 |
| Deykin Aaron | Chief Medical Officer | Mar 16, 2026 | SELL | 894 | $9.29 | $8.3K | Form 4 |
| Sutherland Everett Rand | director, officer: Chief Executive Officer | Mar 16, 2026 | SELL | 2,093 | $9.29 | $19.4K | Form 4 |
| Ambrose Allison | General Counsel | Mar 16, 2026 | SELL | 475 | $9.29 | $4.4K | Form 4 |
| Houghton Adam | Chief Business Officer | Mar 16, 2026 | SELL | 699 | $9.29 | $6.5K | Form 4 |
| GRAY MICHAEL | CFO and COO | Jan 2, 2026 | AWARD | 91,500 | $27.07 | $2.5M | Form 4 |
| GRAY MICHAEL | CFO and COO | Jan 2, 2026 | AWARD | 30,500 | — | — | Form 4 |
| Deykin Aaron | Chief Medical Officer | Jan 2, 2026 | AWARD | 96,000 | $27.07 | $2.6M | Form 4 |
| Deykin Aaron | Chief Medical Officer | Jan 2, 2026 | AWARD | 32,000 | — | — | Form 4 |
| Ambrose Allison | General Counsel | Jan 2, 2026 | AWARD | 51,000 | $27.07 | $1.4M | Form 4 |
| Ambrose Allison | General Counsel | Jan 2, 2026 | AWARD | 17,000 | — | — | Form 4 |
| Houghton Adam | Chief Business Officer | Jan 2, 2026 | AWARD | 75,000 | $27.07 | $2.0M | Form 4 |
| Houghton Adam | Chief Business Officer | Jan 2, 2026 | AWARD | 25,000 | — | — | Form 4 |
| Sutherland Everett Rand | director, officer: Chief Executive Officer | Jan 2, 2026 | AWARD | 225,000 | $27.07 | $6.1M | Form 4 |
| Sutherland Everett Rand | director, officer: Chief Executive Officer | Jan 2, 2026 | AWARD | 75,000 | — | — | Form 4 |
| Renaud Ronald C JR | director | Jun 10, 2025 | AWARD | 17,096 | $11.59 | $198.1K | Form 4 |
| Chimovits Erez | director | Jun 10, 2025 | AWARD | 17,096 | $11.59 | $198.1K | Form 4 |
| Ruddy Marcella K. | director | Jun 10, 2025 | AWARD | 17,096 | $11.59 | $198.1K | Form 4 |
| Beckman Daniella | director | Jun 10, 2025 | AWARD | 17,096 | $11.59 | $198.1K | Form 4 |
| Fleming Harold Edward | director | Jun 10, 2025 | AWARD | 17,096 | $11.59 | $198.1K | Form 4 |
| Ratcliffe Liam | director | Jun 10, 2025 | AWARD | 17,096 | $11.59 | $198.1K | Form 4 |
| Sutherland Everett Rand | director, officer: Chief Executive Officer | Feb 6, 2025 | AWARD | 500,000 | $8.53 | $4.3M | Form 4 |
| GRAY MICHAEL | CFO and COO | Feb 6, 2025 | AWARD | 195,000 | $8.53 | $1.7M | Form 4 |
| Houghton Adam | Chief Business Officer | Feb 6, 2025 | AWARD | 140,000 | $8.53 | $1.2M | Form 4 |
| Deykin Aaron | Chief Medical Officer | Feb 6, 2025 | AWARD | 165,000 | $8.53 | $1.4M | Form 4 |
| Ambrose Allison | General Counsel | Feb 6, 2025 | AWARD | 25,000 | $8.53 | $213.2K | Form 4 |
| Ambrose Allison | General Counsel | Dec 16, 2024 | AWARD | 100,000 | $19.01 | $1.9M | Form 4 |
| Ambrose Allison | Dec 16, 2024 | OTHER | 0 | — | — | Form 4 | |
| Chimovits Erez | director, 10 percent owner: | Oct 15, 2024 | BUY | 660,000 | $17.00 | $11.2M | Form 4 |
| Chimovits Erez | director, 10 percent owner: | Oct 15, 2024 | CONVERSION | 2,887,833 | — | — | Form 4 |
| Chimovits Erez | director, 10 percent owner: | Oct 15, 2024 | BUY | 165,000 | $17.00 | $2.8M | Form 4 |
| Chimovits Erez | director, 10 percent owner: | Oct 15, 2024 | CONVERSION | 721,956 | — | — | Form 4 |
| Chimovits Erez | director, 10 percent owner: | Oct 15, 2024 | CONVERSION | 2,098,000 | — | — | Form 4 |
| Chimovits Erez | director, 10 percent owner: | Oct 15, 2024 | CONVERSION | 789,833 | — | — | Form 4 |
| ORBIMED ADVISORS LLC | director, 10 percent owner: | Oct 15, 2024 | BUY | 660,000 | $17.00 | $11.2M | Form 4 |
| ORBIMED ADVISORS LLC | director, 10 percent owner: | Oct 15, 2024 | CONVERSION | 2,887,833 | — | — | Form 4 |
| ORBIMED ADVISORS LLC | director, 10 percent owner: | Oct 15, 2024 | BUY | 165,000 | $17.00 | $2.8M | Form 4 |
| ORBIMED ADVISORS LLC | director, 10 percent owner: | Oct 15, 2024 | CONVERSION | 721,956 | — | — | Form 4 |
| ORBIMED ADVISORS LLC | director, 10 percent owner: | Oct 15, 2024 | CONVERSION | 2,098,000 | — | — | Form 4 |
| ORBIMED ADVISORS LLC | director, 10 percent owner: | Oct 15, 2024 | CONVERSION | 789,833 | — | — | Form 4 |
| AI Upstream LLC | 10 percent owner | Oct 15, 2024 | CONVERSION | 1,172,410 | — | — | Form 4 |
| AI Upstream LLC | 10 percent owner | Oct 15, 2024 | CONVERSION | 3,147,000 | — | — | Form 4 |
| AI Upstream LLC | 10 percent owner | Oct 15, 2024 | BUY | 1,175,000 | $17.00 | $20.0M | Form 4 |
| AI Upstream LLC | 10 percent owner | Oct 15, 2024 | CONVERSION | 3,147,000 | — | — | Form 4 |
| AI Upstream LLC | 10 percent owner | Oct 15, 2024 | CONVERSION | 1,172,410 | — | — | Form 4 |
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10 percent owner | Oct 15, 2024 | CONVERSION | 894,733 | — | — | Form 4 |
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10 percent owner | Oct 15, 2024 | CONVERSION | 852,940 | — | — | Form 4 |
| Chimovits Erez | director | Oct 10, 2024 | AWARD | 17,096 | $17.00 | $290.6K | Form 4 |
| Ruddy Marcella K. | director | Oct 10, 2024 | AWARD | 17,096 | $17.00 | $290.6K | Form 4 |
| Renaud Ronald C JR | director | Oct 10, 2024 | AWARD | 17,096 | $17.00 | $290.6K | Form 4 |
| Fleming Harold Edward | director | Oct 10, 2024 | AWARD | 17,096 | $17.00 | $290.6K | Form 4 |
| Beckman Daniella | director | Oct 10, 2024 | AWARD | 34,681 | $17.00 | $589.6K | Form 4 |
| Ratcliffe Liam | director | Oct 10, 2024 | AWARD | 17,096 | $17.00 | $290.6K | Form 4 |
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10 percent owner | Oct 10, 2024 | OTHER | 894,733 | — | — | Form 4 |
| Sutherland Everett Rand | director, officer: Chief Executive Officer | Oct 10, 2024 | OTHER | 866,704 | $5.69 | $4.9M | Form 4 |
| Sutherland Everett Rand | director, officer: Chief Executive Officer | Oct 10, 2024 | OTHER | 1,053,799 | $6.59 | $6.9M | Form 4 |
| Chimovits Erez | director, 10 percent owner: | Oct 10, 2024 | OTHER | 0 | — | — | Form 4 |
| Chimovits Erez | director, 10 percent owner: | Oct 10, 2024 | OTHER | 0 | — | — | Form 4 |
| Chimovits Erez | director, 10 percent owner: | Oct 10, 2024 | OTHER | 2,098,000 | — | — | Form 4 |
| Chimovits Erez | director, 10 percent owner: | Oct 10, 2024 | OTHER | 789,833 | — | — | Form 4 |
| Beckman Daniella | Oct 10, 2024 | OTHER | 0 | — | — | Form 4 | |
| Houghton Adam | Chief Business Officer | Oct 10, 2024 | OTHER | 134,140 | $3.45 | $462.8K | Form 4 |
| Houghton Adam | Chief Business Officer | Oct 10, 2024 | OTHER | 11,954 | $4.27 | $51.0K | Form 4 |
| Houghton Adam | Chief Business Officer | Oct 10, 2024 | OTHER | 11,853 | $4.87 | $57.7K | Form 4 |
| Houghton Adam | Chief Business Officer | Oct 10, 2024 | OTHER | 62,940 | $6.59 | $414.8K | Form 4 |
| Ruddy Marcella K. | director | Oct 10, 2024 | OTHER | 13,159 | $3.45 | $45.4K | Form 4 |
| Ruddy Marcella K. | director | Oct 10, 2024 | OTHER | 43,115 | $4.27 | $184.1K | Form 4 |
| Ruddy Marcella K. | director | Oct 10, 2024 | OTHER | 7,867 | $4.87 | $38.3K | Form 4 |
| Ratcliffe Liam | Oct 10, 2024 | OTHER | 0 | — | — | Form 4 | |
| Deykin Aaron | Chief Medical Officer | Oct 10, 2024 | OTHER | 182,431 | $3.45 | $629.4K | Form 4 |
| Deykin Aaron | Chief Medical Officer | Oct 10, 2024 | OTHER | 16,258 | $4.27 | $69.4K | Form 4 |
| Deykin Aaron | Chief Medical Officer | Oct 10, 2024 | OTHER | 11,853 | $4.87 | $57.7K | Form 4 |
| Deykin Aaron | Chief Medical Officer | Oct 10, 2024 | OTHER | 107,207 | $6.59 | $706.5K | Form 4 |
| Fleming Harold Edward | Oct 10, 2024 | OTHER | 0 | — | — | Form 4 | |
| ORBIMED ADVISORS LLC | director, 10 percent owner: | Oct 10, 2024 | OTHER | 0 | — | — | Form 4 |
| ORBIMED ADVISORS LLC | director, 10 percent owner: | Oct 10, 2024 | OTHER | 0 | — | — | Form 4 |
| ORBIMED ADVISORS LLC | director, 10 percent owner: | Oct 10, 2024 | OTHER | 2,098,000 | — | — | Form 4 |
| ORBIMED ADVISORS LLC | director, 10 percent owner: | Oct 10, 2024 | OTHER | 789,833 | — | — | Form 4 |
| Renaud Ronald C JR | director | Oct 10, 2024 | OTHER | 107,312 | $3.45 | $370.2K | Form 4 |
| Renaud Ronald C JR | director | Oct 10, 2024 | OTHER | 9,563 | $4.27 | $40.8K | Form 4 |
| Renaud Ronald C JR | director | Oct 10, 2024 | OTHER | 31,470 | $4.87 | $153.3K | Form 4 |
| Renaud Ronald C JR | director | Oct 10, 2024 | OTHER | 113,554 | $6.59 | $748.3K | Form 4 |
| GRAY MICHAEL | CFO and COO | Oct 10, 2024 | OTHER | 152,450 | $5.69 | $867.4K | Form 4 |
| AI Upstream LLC | 10 percent owner | Oct 10, 2024 | OTHER | 3,000,000 | — | — | Form 4 |